[go: up one dir, main page]

DK0480949T3 - Fremstilling af virus og oprensning af virale kappeproteiner til vaccineanvendelse - Google Patents

Fremstilling af virus og oprensning af virale kappeproteiner til vaccineanvendelse

Info

Publication number
DK0480949T3
DK0480949T3 DK90909595.2T DK90909595T DK0480949T3 DK 0480949 T3 DK0480949 T3 DK 0480949T3 DK 90909595 T DK90909595 T DK 90909595T DK 0480949 T3 DK0480949 T3 DK 0480949T3
Authority
DK
Denmark
Prior art keywords
viruses
purification
preparation
envelope proteins
viral envelope
Prior art date
Application number
DK90909595.2T
Other languages
English (en)
Other versions
DK0480949T4 (da
Inventor
Mary Elizabeth Ewasyshyn
Anne-Marie Bonneau
Michel Henri Klein
Barry Ian Caplan
Original Assignee
Connaught Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10659282&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0480949(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Connaught Lab filed Critical Connaught Lab
Application granted granted Critical
Publication of DK0480949T3 publication Critical patent/DK0480949T3/da
Publication of DK0480949T4 publication Critical patent/DK0480949T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK90909595T 1989-06-29 1990-06-28 Fremstilling af virusvaccine DK0480949T4 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898914968A GB8914968D0 (en) 1989-06-29 1989-06-29 Production of virus and purification of viral envelope proteins for vaccine use

Publications (2)

Publication Number Publication Date
DK0480949T3 true DK0480949T3 (da) 1995-12-18
DK0480949T4 DK0480949T4 (da) 2004-12-06

Family

ID=10659282

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90909595T DK0480949T4 (da) 1989-06-29 1990-06-28 Fremstilling af virusvaccine

Country Status (10)

Country Link
US (2) US6455050B1 (da)
EP (1) EP0480949B2 (da)
JP (1) JP2599503B2 (da)
AT (1) ATE130198T1 (da)
CA (1) CA2056437C (da)
DE (1) DE69023648T3 (da)
DK (1) DK0480949T4 (da)
ES (1) ES2078971T5 (da)
GB (1) GB8914968D0 (da)
WO (1) WO1991000104A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU677090B2 (en) 1993-08-06 1997-04-10 Connaught Laboratories Limited Inactivated respiratory syncytial viral vaccines
US7223410B1 (en) 1994-08-05 2007-05-29 Sanofi Pasteur Limited Inactivated respiratory syncytial viral vaccines
US6764682B1 (en) * 1994-06-16 2004-07-20 Aventis Pasteur Limited Adjuvant compositions containing more than one adjuvant
MX9702396A (es) * 1994-10-05 1997-12-31 Univ Vanderbilt Interleukina-12 como adyuvante para vacunas de paramyxoviridae.
US6290971B1 (en) 1995-06-15 2001-09-18 Aventis Pasteur Limited Adjuvant compositions comprising a mineral salt and another immunostimulating compound
US6165774A (en) * 1995-09-22 2000-12-26 Connaught Laboratories Limited Parainfluenza virus glycoproteins and vaccines
US6020182A (en) * 1996-07-12 2000-02-01 Connaught Laboratories Limited Subunit respiratory syncytial virus vaccine preparation
KR101229202B1 (ko) 2002-04-26 2013-02-01 메디뮨 엘엘씨 인플루엔자 바이러스의 생산을 위한 다중 플라스미드 시스템
US7465456B2 (en) 2002-04-26 2008-12-16 Medimmune, Llc Multi plasmid system for the production of influenza virus
CA2517181C (en) 2003-02-25 2013-07-16 Medimmune Vaccines, Inc. Methods of producing influenza vaccine compositions
US20060110406A1 (en) 2003-02-25 2006-05-25 Medimmune Vaccines, Inc. Refrigerator-temperature stable influenza vaccine compositions
EP1697521B1 (en) 2003-12-23 2010-06-02 MedImmune, LLC Multi plasmid system for the production of influenza virus
WO2008157583A1 (en) 2007-06-18 2008-12-24 Medimmune, Llc Influenza b viruses having alterations in the hemaglutinin polypeptide
RU2531510C2 (ru) * 2008-12-09 2014-10-20 Новавакс, Инк. Модифицированные f протеины sv и способы их применения
US11446374B2 (en) 2008-12-09 2022-09-20 Novavax, Inc. Modified RSV F proteins and methods of their use
SG184833A1 (en) 2010-04-14 2012-11-29 Emd Millipore Corp Methods of producing high titer, high purity virus stocks and methods of use thereof
EP4494650A3 (en) 2015-09-03 2025-03-26 Novavax, Inc. Vaccine compositions having improved stability and immunogenicity
WO2019023196A1 (en) 2017-07-24 2019-01-31 Novavax, Inc. METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY DISEASE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4699785A (en) * 1984-09-18 1987-10-13 The Regents Of The University Of California Cell line producing feline leukemia virus
WO1989005823A1 (en) * 1987-12-23 1989-06-29 The Upjohn Company Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus
AU611784B2 (en) * 1988-04-22 1991-06-20 Pharmacia & Upjohn Company Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3

Also Published As

Publication number Publication date
WO1991000104A1 (en) 1991-01-10
DK0480949T4 (da) 2004-12-06
ATE130198T1 (de) 1995-12-15
EP0480949B2 (en) 2004-08-04
US6455050B1 (en) 2002-09-24
DE69023648T2 (de) 1996-05-02
JPH04502410A (ja) 1992-05-07
EP0480949A1 (en) 1992-04-22
GB8914968D0 (en) 1989-08-23
CA2056437C (en) 1996-02-06
US6306637B1 (en) 2001-10-23
CA2056437A1 (en) 1990-12-30
DE69023648T3 (de) 2005-02-03
DE69023648D1 (de) 1995-12-21
ES2078971T3 (es) 1996-01-01
JP2599503B2 (ja) 1997-04-09
EP0480949B1 (en) 1995-11-15
ES2078971T5 (es) 2005-03-16

Similar Documents

Publication Publication Date Title
DK0480949T3 (da) Fremstilling af virus og oprensning af virale kappeproteiner til vaccineanvendelse
DK1213030T3 (da) Fremgangsmåde til fremstilling af biologiske produkter i protein-fri kultur
DK0527760T3 (da) Fremgangsmåder og præparater til vaccination mod HIV
BR8701528A (pt) Proteina,sequencia de dna,vetor recombinante,organismo celular,processos para producao de uma proteina e para a preparacao de um organismo unicelular,processos para a deteccao da presenca de anticorpos e de virus de aids,processos para a preparacao de uma vacina e para a preparacao de anticorpos,formulacao de vacina,anticorpos,uso,vacina,kit de teste e metodo para a prevencao de aids
PT102022A (pt) Processo para a producao e purificacao de astaloglicoprotetinas adequadas para uso em vacinas e conjunto de materiais de ensaio para detectar a sua presenca
DK33190D0 (da) Hiv-3 retrovirus og anvendelse heraf
ATE380822T1 (de) Funf-helix protein
ATE171471T1 (de) Isolierte virale proteine als cytokinantagonisten
ATE231557T1 (de) Detektion des hepatis-c virus.
UA35639C2 (uk) Спосіб одержання композиції очищеного капсидного білка вірусу папіломи людини
DK11187A (da) Dna-sekvenser der koder for proteiner med husi-type i inhibitorers biologiske aktivitet, biotekniske fremgangsmaader til fremstilling af proteinerne o g farmaceutiske praeparater der indeholder dem
WO2002038793A3 (en) Hepatitis c virus constructs characterized by high efficiency replication
ES2080047T3 (es) Peptidos hiv y metodos para la deteccion de hiv.
DE69736779D1 (de) Zusammensetzungen von rekombinanten papillomavirus vakzinen
ATE435034T1 (de) Expression und charakterisierung eines hiv-1 hüllproteins, das mit einer breitreaktiven neutralisierenden antikörperantwort assoziiert ist.
DK0491713T3 (da) Rubella El-peptider og C-peptider
AU2190288A (en) Vector for the expression of proteins of the HIV-2 virus, one of the casual agents of AIDS, cell culture infected or transformed by this vector, proteins obtained, vaccine and antibodies obtained
HK1048335A1 (en) Recombinant bifunctional fusion proteins for the clearance of variable viruses
EP0888046A4 (en) METHOD FOR PROTEIN PRODUCTION BY MEANS OF A MITOCHONDRIAL TRANSLATION SYSTEM.
ATE384794T1 (de) Neue post-transkriptionelle regulationselemente und deren verwendung
SU1533329A1 (ru) Штамм гибридных культивируемых клеток животных mus musculus, используемый для получения моноклональных антител к белку е оболочки вирусов комплекса клещевого энцефалита
SU1545614A1 (ru) Штамм гибридных культивируемых клеток животных mus musculus, используемый для получения моноклональных антител к белку е оболочки вирусов комплекса клещевого энцефалита
DK589586A (da) Ekspression og diagnostisk anvendelse af gag-kodede peptider, der er immunologisk reaktive med antistoffer til lav.
GB8913665D0 (en) Method of preparing vaccines against rna viruses